Home - Products - Others - Other Targets - CFTR (108-117), Pseudomonas aeruginosa Inhibitor

CFTR (108-117), Pseudomonas aeruginosa Inhibitor

CAS No. ———

CFTR (108-117), Pseudomonas aeruginosa Inhibitor( ——— )

Catalog No. M41328 CAS No. ———

CFTR (108-117), Pseudomonas aeruginosa Inhibitor

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • Description
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1252.27
  • Molecular Formula
    C51H77N15O22
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EGA

    EGA inhibits the intoxication of lethal toxins and prevents the entry of a variety of other acid-dependent bacterial toxins and viruses into mammalian cells.EGA is a powerful tool for the study of membrane trafficking and can be used to treat infectious diseases.

  • Ebeiedinone

    Ebeiedinone, a steroidal alkaloid from Fritillaria species, inhibits the bioactivity of human whole blood cholinesterase (ChE) at the concentration of 0.1 mM, with the inhibitory effects of 69.0%.

  • Pivagabine

    Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.